SERPINE1 and obstructive sleep apnea syndrome: Finally, we will discuss some of the therapeutic approaches to reduce PAI-1 levels, which may hold promise as adjuvant therapies in OSA since existing treatments (e.g., continuous positive airway pressure (CPAP)) appear to be ineffective in reversing or mitigating the frequency and severity of cardiovascular events in OSA patients [43,44].